South SA - Search Results

1

Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats.

Chiang PC, South SA, Daniels JS, Anderson DR, Wene SP, Albin LA, Mourey RJ, Selbo JG. Chiang PC, et al. Among authors: south sa. J Pharm Sci. 2009 Jan;98(1):248-56. doi: 10.1002/jps.21425. J Pharm Sci. 2009. PMID: 18449936

2

Utilizing a novel tandem oral dosing strategy to enhance exposure of low-solubility drug candidates in a preclinical setting.

Chiang PC, South SA, Foster KA, Daniels JS, Wene SP, Albin LA, Thompson DC. Chiang PC, et al. Among authors: south sa. J Pharm Sci. 2010 Jul;99(7):3132-40. doi: 10.1002/jps.22092. J Pharm Sci. 2010. PMID: 20229600

3

A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation.

Mourey RJ, Burnette BL, Brustkern SJ, Daniels JS, Hirsch JL, Hood WF, Meyers MJ, Mnich SJ, Pierce BS, Saabye MJ, Schindler JF, South SA, Webb EG, Zhang J, Anderson DR. Mourey RJ, et al. Among authors: south sa. J Pharmacol Exp Ther. 2010 Jun;333(3):797-807. doi: 10.1124/jpet.110.166173. Epub 2010 Mar 17. J Pharmacol Exp Ther. 2010. PMID: 20237073

4

The impact of dosing interval in a novel tandem oral dosing strategy: enhancing the exposure of low solubility drug candidates in a preclinical setting.

Chiang PC, South SA, Wene SP. Chiang PC, et al. Among authors: south sa. J Drug Deliv. 2011;2011:528284. doi: 10.1155/2011/528284. Epub 2011 Jan 12. J Drug Deliv. 2011. PMID: 21490753 Free PMC article.

5

Inhibition of hepatobiliary transporters by a novel kinase inhibitor contributes to hepatotoxicity in beagle dogs.

Daniels JS, Lai Y, South S, Chiang PC, Walker D, Feng B, Mireles R, Whiteley LO, McKenzie JW, Stevens J, Mourey R, Anderson D, Davis Ii JW. Daniels JS, et al. Drug Metab Lett. 2013 Mar;7(1):15-22. doi: 10.2174/18723128112066660018. Drug Metab Lett. 2013. PMID: 24138031

6

Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers.

South SA, Vance H, Farrell C, DiCioccio RA, Fahey C, Piver MS, Rodabaugh KJ. South SA, et al. Cancer. 2009 Jan 15;115(2):324-33. doi: 10.1002/cncr.24012. Cancer. 2009. PMID: 19117025 Free article.

7

Uterine carcinosarcoma associated with hereditary nonpolyposis colorectal cancer.

South SA, Hutton M, Farrell C, Mhawech-Fauceglia P, Rodabaugh KJ. South SA, et al. Obstet Gynecol. 2007 Aug;110(2 Pt 2):543-5. doi: 10.1097/01.AOG.0000275262.60526.01. Obstet Gynecol. 2007. PMID: 17666659

8

Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin.

Raskin P, Klaff L, McGill J, South SA, Hollander P, Khutoryansky N, Hale PM; Repaglinide vs. Nateglinide Metformin Combination Study Group. Raskin P, et al. Among authors: south sa. Diabetes Care. 2003 Jul;26(7):2063-8. doi: 10.2337/diacare.26.7.2063. Diabetes Care. 2003. PMID: 12832314 Clinical Trial.

9

Myelin basic protein (MBP) and MBP peptides are mitogens for cultured astrocytes.

South SA, Deibler GE, Tzeng SF, Badache A, Kirchner MG, Muja N, De Vries GH. South SA, et al. Glia. 2000 Jan 1;29(1):81-90. doi: 10.1002/(sici)1098-1136(20000101)29:1<81::aid-glia8>3.0.co;2-o. Glia. 2000. PMID: 10594925

10

Insulin-dependent diabetes mellitus and menstrual dysfunction.

Griffin ML, South SA, Yankov VI, Booth RA Jr, Asplin CM, Veldhuis JD, Evans WS. Griffin ML, et al. Among authors: south sa. Ann Med. 1994 Oct;26(5):331-40. doi: 10.3109/07853899409148347. Ann Med. 1994. PMID: 7826593 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page